Analyst Ratings for Pacific Biosciences of California (PACB) [Sells]
PACB Rating Summary
PACB Price Target Summary
- Highest: $13.00 (Piper Sandler)
- Lowest: $2.00 (Nephron)
- Average: $7.29
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$7.29 (+436.2%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
Avg. $ Target:
$7.29 (+436.2%)
* Over Last 12-Mos
Rating Score: 4.5 / 10
Percentile Rank: 46%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|
